Please login to the form below

Not currently logged in
Email:
Password:

The Access Partnership hires Mike Mallinson

He joins with more than 30 years’ experience gained both on agency and client-side

London-based The Access Partnership, part of the The Research Partnership, has appointed Mike Mallinson as president of the market access consultancy firm.

Mallinson has more than 30 years' experience, gained both on agency and client-side. Most recently he served as UK MD for market access, and pricing and reimbursement specialists, Double Helix Consulting, while prior to this he established a payer, pricing, reimbursement and market access practice within GfK's healthcare division.

In his new role, Mallison will be supported by Rob White, global director of market access and Dr Shrinivas Rao Mukku, global director of pricing and reimbursement.

“I am delighted to be taking on this challenging new position,” said Mallinson.

“Our aim is for The Access Partnership to become the preferred commercial partner for delivering market access solutions, by gaining a reputation for delivering the best payer and key stakeholder insights and outstanding strategic consulting services.

“We recognise the access challenges facing our clients, particularly across the Tier I and Tier II emerging markets - having an Asia Pacific presence will mean we are well placed to meet our clients' needs in this region.”

2nd November 2012

From: Marketing, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics